eli lilly tirzepatide patent expiration date Looming GLP-1 drug expirations draw generics firms Ozempic's Patent Protection Starts to

Description

Dula also significantly reduced the expression of transforming growth factor-1 (TGF-1), phosphatidylinositol-3-kinase (PI3K), protein kinase B (AKT) signaling pathway, and the inflammatory cytokines: nuclear factor kappa B (NF-B), interleukin-6 (IL-6), and interferon- (IFN-) in colonic cellular structures

We found that GLP-1 receptor agonists were associated with a lower risk of age-related macular degeneration (especially dry AMD) in adults with diabetes and obesity compared with metformin or other weight-loss medications

Compared with SGLT-2 inhibitor use, GLP-1 receptor agonist use was not associated with an increased risk of pulmonary aspiration (pooled risk ratio 0.98, 95% CI 0.73 to 1.31), although it was associated with a higher risk for discontinuation of endoscopy (1.99, 1.56 to 2.53)